JPS5874611A - Material, unit and process for separating t-cells - Google Patents

Material, unit and process for separating t-cells

Info

Publication number
JPS5874611A
JPS5874611A JP56172153A JP17215381A JPS5874611A JP S5874611 A JPS5874611 A JP S5874611A JP 56172153 A JP56172153 A JP 56172153A JP 17215381 A JP17215381 A JP 17215381A JP S5874611 A JPS5874611 A JP S5874611A
Authority
JP
Japan
Prior art keywords
cells
protein
cell
separation material
average pore
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56172153A
Other languages
Japanese (ja)
Other versions
JPS6245206B2 (en
Inventor
Tsutae Akao
赤尾 伝
Tsutomu Abe
力 阿部
Akihiko Ikeda
章彦 池田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Industry Co Ltd, Asahi Kasei Kogyo KK filed Critical Asahi Chemical Industry Co Ltd
Priority to JP56172153A priority Critical patent/JPS5874611A/en
Publication of JPS5874611A publication Critical patent/JPS5874611A/en
Publication of JPS6245206B2 publication Critical patent/JPS6245206B2/ja
Granted legal-status Critical Current

Links

Abstract

PURPOSE:A hydrophobic and water-insoluble porous solid with a specific average pore diameter, to which an animal serum protein is adhered, is used as a T-cell separator to separate T-cells playing a role in immunological reactions such as inhibition of antibody production from a lymphocyte suspension. CONSTITUTION:An amimal serum protein, especially a serum protein from mammarian fetus, is adhered to a hydrophbic, water-insoluble porous solid with an average pore diameter of 500-5,000Angstrom to prepare a T-cell separateor. A column 3 with inlet and outlet 1, 2 of which at least outlet 2 has a filter 4 is filled with the above T-cell separator and the resultant device is brought into contact with a lymphocyte suspension in a solution containing more than 0.1g/dl of protein to separate T-cells in high purity and high yield without immunoligical stimulation by use of less amount of protein than in the conventional process rapidly, simply in sterility.

Description

【発明の詳細な説明】 本発明は、白血球浮遊液からT細胞を分、離する分離材
、および該分離材を用い九丁細胞分離器、さらに該分離
分離材を用いてT細胞を分離する方′7=二二’57!
Ill&□、i<5i=l−4’l&1Mし良ヒツジ赤
血球とpゼットを形成するリンパ球を云い2、非T細胞
と社、〒細胞と認識されないリンパ球、単球および顆粒
球を云う。
Detailed Description of the Invention The present invention provides a separation material for separating and separating T cells from a leukocyte suspension, a Kucho cell separator using the separation material, and a method for separating T cells using the separation material. Ho'7=22'57!
Ill&□, i<5i=l-4'l&1M, refers to lymphocytes that form p-cells with good sheep red blood cells2, non-T cells refers to lymphocytes, monocytes, and granulocytes that are not recognized as cells.

、T細胞は末、梢血リンパ球の70〜85−程度を段階
の分離手段で獲得することは不可能とされている。また
種々の手段を組合せ、高純度高収率、で、かつ生存率良
く獲得することは、免疫学研究の必須の手法であり、そ
れ故また多くの問題を有している。
It is said that it is impossible to obtain T cells in the 70 to 85 range of peripheral blood lymphocytes by means of step separation. Furthermore, combining various means to obtain high purity, high yield, and high survival rate is an essential technique for immunological research, and therefore there are many problems.

従来の末梢血からのT細胞の分離方法は、いずれもまず
、ソデイウムメトリゾエイトーフイーコール混液などの
高密度岬張液を用いた比重遠心法によシ、白血球のうち
70〜909!のリンパ球を含む白血球浮遊液を獲得し
、次いで、これを分離処理している。この後続する分離
処理の主なもの社次の三つの方法が知られている。
Conventional methods for isolating T cells from peripheral blood all involve a specific gravity centrifugation method using a high-density suspension solution such as a sodium metrizoate-weight-equal mixture. A white blood cell suspension containing lymphocytes is obtained and then subjected to separation processing. The following three main methods are known for this subsequent separation process.

1) ?細胞とロゼツト形成能を有するノイラミニダー
ゼ処理したヒツジ赤血球を上記前処理液に添加し、数時
間以上冷所で放置後、再度比重遠心法を施してT細胞を
獲得する。
1)? Cells and neuraminidase-treated sheep red blood cells having the ability to form rosettes are added to the above pretreatment solution, left in a cold place for several hours or more, and then subjected to density centrifugation again to obtain T cells.

2)T細胞の異物表面゛に対する付着性が非T細胞にく
らべ低−性質を利用して、上記前処理液をナイロン繊維
に接触させ、繊維に付着しにくい分画としてT細胞を獲
得する。
2) Taking advantage of the fact that T cells have a lower adhesion to foreign surfaces than non-T cells, the pretreatment solution is brought into contact with nylon fibers to obtain T cells as a fraction that is less likely to adhere to the fibers.

3)螢光標識したT細胞を認識する抗血清を用い、上記
前処理液中のT細胞を螢光染色し、フルオレセインセル
ソーターを用いて螢光細胞分画としてT細胞を獲得する
3) T cells in the pretreatment solution are fluorescently stained using an antiserum that recognizes fluorescently labeled T cells, and T cells are obtained as a fluorescent cell fraction using a fluorescein cell sorter.

第1の方法は、ヒツジ赤血球とリンパ球を共存させるこ
とによシ、リンパ球を刺激してしまうという欠点を有し
、免疫系におけるT細胞の役割を解明する研究目的には
適用しがたい。
The first method has the disadvantage of stimulating lymphocytes by allowing sheep red blood cells and lymphocytes to coexist, and is difficult to apply for research purposes to elucidate the role of T cells in the immune system. .

第2の方法は、T細胞と非T細胞の大部分は分−が十分
にされず、純度の高いT細胞はわずかじか得られない。
In the second method, the majority of T cells and non-T cells are not sufficiently separated, and only a few highly pure T cells are obtained.

@3の方法は、理論的KFi最も高い純度のT細胞を獲
得しうる方法であるが、抗血清を用いる九めに細胞に刺
激や損傷を与えてしまうこと、1個1個?細胞を選別し
てゆくという操作が必須であるため、10マ〜10・個
程度のリンパ球の大量取得が困難であるなどの欠点を有
する。
The method @3 is a method that can theoretically obtain T cells with the highest purity in terms of KFi, but the problem with using antiserum is that it stimulates and damages the cells one by one. Since the operation of sorting cells is essential, it has drawbacks such as difficulty in obtaining a large number of lymphocytes of about 10 to 10 cells.

本発明者らは、かかるT細胞分離方法の現状をふまえ、
T#l胞を高純駿、高収率かつ細胞に免疫的刺激管与え
ずに□獲得することを目的とし、!細胞および非T細胞
の異物表面に対する付着現象に詳細な検討を加えた結果
、多孔性表面を有する水不溶性かつ疎水性の固体が、T
細胞′の選択的分離に特許出願を行なっているttry
願昭56−ssy。
The present inventors, based on the current state of such T cell isolation methods,
The aim is to obtain T#l cells with high purity and high yield without providing immune stimulation to the cells. As a result of detailed studies on the adhesion phenomenon of cells and non-T cells to foreign surfaces, we found that a water-insoluble and hydrophobic solid with a porous surface
ttry, which has applied for a patent for the selective separation of cells
Gansho 56-ssy.

および特願昭56二age−a4)。and patent application 1982-A4).

本発明者らは、!細胞分離操祿をさらに容易かつ簡略化
すべく引き続き鋭意検討i行なった結果、多孔性を有す
尿水溶性かつ疎水性の固体に動物血清蛋白質を付着、乾
燥したもの、をT細胞分離材として用い鼠”ことにより
、分離操作がよシ簡便に□なシ、分離時−用蛋白質量の
低減−□化が祈能+あり、さらに無菌操作が容易となる
効果を見い出し、□本発明を完成するに至った= すなわち、本発明は、動物血清蛋白質を付着せしめた5
00A以上500◎1未満の平均−梶棒を有する水不溶
性かつ疎水性の多孔性、一体よIる白血球浮遊液から丁
細胞を分離す□゛るT細胞分離材、および該分離材を液
の□出入口を有し、咳゛液“□出口側にフィルターを設
i九−2′ム内に充填□して□なるT細胞分離器、なら
びに該分離材に0.1t/dJ以上の蛋白質共存下で白
血球−透液□を接触することを特徴とするT細胞分離方
法である。
The inventors! As a result of continuing intensive studies to further simplify and simplify the cell separation procedure, we used a porous urine water-soluble and hydrophobic solid to which animal serum proteins were attached and dried, as a T cell separation material. We have discovered the effects of making the separation process easier and easier, reducing the amount of protein used during separation, and facilitating the aseptic process, and completed the present invention. = In other words, the present invention provides 5
A water-insoluble and hydrophobic porous material having an average diameter of 00 A or more and less than 500 A T cell separator, which has an inlet and an outlet and is filled with a cough liquid "□" chamber with a filter on the outlet side □ and □ in the presence of 0.1 t/dJ or more of protein in the separation material. This is a T cell separation method characterized by contacting leukocytes with permeated liquid □.

以下、本発明の構成について説明する。The configuration of the present invention will be explained below.

本発明における動物血清蛋白質を付着せしめる固体は、
疎水性であることが必要であり、具体的に轄、これらの
素材として、エチレン、プνビレン、塩化ビニル、酢酸
ビニル、スチレン、ジビニルベンゼン、アクリロニトリ
ル、メタクリル酸メチルなどの重合体およ□び共重合体
、ま九は′ナイロン、ポリカーボネート、ポリエチレン
テレフタレート、ポリエステル共重合体などがある。
The solid to which animal serum proteins are attached in the present invention is
They must be hydrophobic, and these materials include polymers such as ethylene, vinylene, vinyl chloride, vinyl acetate, styrene, divinylbenzene, acrylonitrile, methyl methacrylate, etc. Copolymers include nylon, polycarbonate, polyethylene terephthalate, and polyester copolymers.

上記の疎水性固体の調製方法は特に限定され表いが、重
合過程で比較的自由に多孔化高分子を調製できる。特に
スチレンなどのモノビニル単量体とジビニルベンゼンな
どの架橋重合性単量体を共重合して得られる多孔性共重
合体が好ましい。′ζζで云うモノビニル単量体とは、
はとんどすべてのビニル単量体が該当する。すなわち、
スチレン、メチルスチレン、ジフェニルエチレン、エチ
ルスチレン、ジメチルスチレン、ビニルナフタリン、ビ
ニルフエナントレy1 ビニルメシチレン、墨e 4 
# 6− )ジメチルスチレン、1−ビニル−2−エチ
ルアセチレン等の炭化水素化合物:クロルスチレン、メ
トキシスチレン、ブロムスチレン、シアノスチレン、フ
ルオルスチレン、ジクロルスチレン、N、N−ジメチル
アミノスチレン、ニトロ哀チレン、クロルメチルスチレ
ン、トリフルオルスチレン、トリフルオルメチルスチレ
ン、アミノスチレン等のスチレ/誘導体:メチルビニル
スルフィト、フェニルビニルスルフィド等のビニルスル
フィド鱒導体:アクリロニトリル、メタクリレートリル
、α−7セトキシアクリロニトリル尋の7クリロニトリ
ル誘導体ニアクリル酸、メーク9ル酸ニアクリル酸メチ
ル、アクリル酸ラウリル、アクリル酸りpルメチル、ア
七トキシアクリル酸エチル等のアクリル酸エステル:メ
タクリル酸シクロヘキシル、メタクリル酸ジメチルアミ
ノエチル、メタクリル酸グリシジル、メタクリル酸テト
ラヒドロフルフリル、メタクリル酸ヒドロキシエチル等
のメタクリル酸エステル二マレイン酸ジエチル、フマル
酸ジエチル:メチルビニルケトン、エチルイソプロペニ
ルケトン等のビニルケトン、塩化ビニリデン、臭化ビニ
リデン、シアン化ビニリデン等のビニリデン化合物ニア
クリルアミド、メタクリルアミド、N−ブトキシメチル
アクリルアミド、N−フェニルアクリルアミド、ジアセ
トンアクリルアミド、N、N−ジメチルアミノエチ次ア
クリルアミド等のアクリルアミド誘導体:酢酸ビニル、
酪酸ビニル、カプリン酸ビニル等の脂肪酸ビニル−導体
:チオメタクリル酸フェニル、チオアクリル酸メチル、
チオ酢酸ビニル等のチオ脂肪酸−導体:サラにN−ビニ
ルスクシンイミド、N−ビニルピロリドン、N−ビニル
7タルイミド、N−ビニルカルバソール・、ビニルフラ
ン、2−ビニルベール、メチルビニルイミダゾール、ビ
ニルピラゾール、ビニルオキサゾリドン、ビニルチアゾ
ール、ビニルナト2ゾール、ビニルピリジン、メチルビ
ニルピリジン、2.4−ジメチル−6−ビニルピリジン
、ビニルキノリン等の異節積状ビニル化合物がある。
Although the method for preparing the hydrophobic solid described above is not particularly limited, a porous polymer can be prepared relatively freely during the polymerization process. Particularly preferred is a porous copolymer obtained by copolymerizing a monovinyl monomer such as styrene and a crosslinkable monomer such as divinylbenzene. The monovinyl monomer referred to as ′ζζ is
This applies to almost all vinyl monomers. That is,
Styrene, methylstyrene, diphenylethylene, ethylstyrene, dimethylstyrene, vinylnaphthalene, vinylphenanthrene y1 vinylmesitylene, ink e 4
#6-) Hydrocarbon compounds such as dimethylstyrene and 1-vinyl-2-ethylacetylene: chlorstyrene, methoxystyrene, bromustyrene, cyanostyrene, fluorostyrene, dichlorostyrene, N,N-dimethylaminostyrene, nitro Styrene/derivatives such as styrene, chloromethylstyrene, trifluorostyrene, trifluoromethylstyrene, aminostyrene, etc.: Vinyl sulfides such as methyl vinyl sulfite, phenyl vinyl sulfide, etc. Trout conductors: acrylonitrile, methacrylaterile, α-7cetoxyacrylonitrile Acrylic acid esters such as 7-acrylonitrile derivatives niacrylic acid, methyl niacrylate, lauryl acrylate, p-methyl acrylate, ethyl a7toxyacrylate: cyclohexyl methacrylate, dimethylaminoethyl methacrylate, methacryl Methacrylic acid esters such as glycidyl acid, tetrahydrofurfuryl methacrylate, and hydroxyethyl methacrylate Diethyl dimaleate, diethyl fumarate: Vinyl ketones such as methyl vinyl ketone and ethyl isopropenyl ketone, vinylidene chloride, vinylidene bromide, vinylidene cyanide, etc. Acrylamide derivatives such as vinylidene compounds niacrylamide, methacrylamide, N-butoxymethylacrylamide, N-phenylacrylamide, diacetone acrylamide, N,N-dimethylaminoethyl acrylamide: vinyl acetate,
Fatty acid vinyl conductors such as vinyl butyrate and vinyl caprate: phenyl thiomethacrylate, methyl thioacrylate,
Thio fatty acid conductors such as vinyl thioacetate: N-vinyl succinimide, N-vinyl pyrrolidone, N-vinyl 7-thallimide, N-vinyl carbazole, vinyl furan, 2-vinyl veil, methyl vinyl imidazole, vinyl pyrazole, There are heteroarticulated vinyl compounds such as vinyl oxazolidone, vinylthiazole, vinylnato dizole, vinylpyridine, methylvinylpyridine, 2,4-dimethyl-6-vinylpyridine, and vinylquinoline.

また、架橋重合性単量体としては、ジビニルベンゼン、
ジビニルトルエン、ジビニルキシレン、ジビニルナフタ
リン、ジビニルエチルベンゼン、ジビニルフェナントレ
ン、トリビニルベンゼン、ジビニルジフェニル、ジビニ
ルジフェニルメタン、ジビニルジベンジル、ジビニルフ
ェニルエーテル、ジビニルジフェニルスルフィド、ジビ
ニルジフェニル7 ミン、ジビニルスルホン、ジビニル
ケトン、ジビニルフラン、ジビニルピリジン、ジビニル
キノリン、ジ(ビニルピリジノエチル)エチレンジアミ
ン、フタル酸ジアリル、マレイン酸ジアリル、フマル酸
ジアリル、コハク酸ジアリル、炭酸ジアリル、シェラ酸
ジアリル、アジピン酸ジアリル、セバシン酸ジアリル、
酒石酸ラウリル、ジアリルアミン、トリアリ′ルアミン
、リン酸トリアリル、トリカルバリル識トリアリル、ア
コニット酸トリアリル、”クエン酸トリアリル、N、N
’−エチレンジアクリルアミド、N、N’−メチ″レン
ジアクリルアミド、N、N’−メチレンジメタクリルア
建ド、エチレングリコールジメタクリレート、トリエ゛
チレングリi−ルジメタクリレート、ポリエチレングリ
コールジメタクリレート、トリメチロールプロパントリ
メタクリレート、ペンタエリスリトールテトラメタクリ
レート、1.3−プチレレグリコールジアクリレート、
1,6−ヘキサンジオールジアクリレート、トリメチル
プロパントリアクリレート、ペンタエリスリトールテト
ラアクリレート、トリアリルイノシアヌレート、1.!
1.5−)リアクロイルへキサヒドロ−1,’ 、 、
5”、 s、=トリアジン−ジアリールメラミン等が含
まれる。
In addition, as the cross-linked polymerizable monomer, divinylbenzene,
Divinyltoluene, divinylxylene, divinylnaphthalene, divinylethylbenzene, divinylphenanthrene, trivinylbenzene, divinyldiphenyl, divinyldiphenylmethane, divinyldibenzyl, divinylphenyl ether, divinyldiphenyl sulfide, divinyldiphenyl7mine, divinylsulfone, divinylketone, divinylfuran , divinylpyridine, divinylquinoline, di(vinylpyridinoethyl)ethylenediamine, diallyl phthalate, diallyl maleate, diallyl fumarate, diallyl succinate, diallyl carbonate, diallyl sherate, diallyl adipate, diallyl sebacate,
Lauryl tartrate, diallylamine, triallylamine, triallyl phosphate, triallyl tricarbaryl, triallyl aconitate, triallyl citrate, N,N
'-ethylene diacrylamide, N,N'-methylene diacrylamide, N,N'-methylene dimethacrylate, ethylene glycol dimethacrylate, triethylene glycol dimethacrylate, polyethylene glycol dimethacrylate, trimethylolpropane trimethacrylate methacrylate, pentaerythritol tetramethacrylate, 1,3-butyler glycol diacrylate,
1,6-hexanediol diacrylate, trimethylpropane triacrylate, pentaerythritol tetraacrylate, triallylinocyanurate, 1. !
1.5-) Liacroylhexahydro-1,' , ,
5'', s,=triazine-diarylmelamine and the like.

本発明にシける疎水性の固体は、平滑な表面の場合は十
分に非T細胞を付着できず、SOO!以上5ooo!未
満、よシ好ましくは600x以上asooX未満、特に
好ましくは100◎ス以上zsoojL未満の平均細孔
径を有するものが用いられる。
When the hydrophobic solid according to the present invention has a smooth surface, non-T cells cannot sufficiently attach to it, and SOO! That's 5ooo! The average pore diameter used is preferably 600x or more and less than asooX, particularly preferably 100◎ or more and less than zsoojL.

う平均細孔径は、水銀圧入式ボロシメ ここでい −ターによシ測定される。The average pore diameter is determined by the mercury intrusion method. Stay here - Measured by tar.

この方法は多孔性物質に水銀を圧入して行き、浸入した
水銀量から水銀孔量(単位重量あた′シの浸入した水銀
量)を求めるとともに、細孔の直径とその孔に水銀を圧
入するに要する圧力社反比例するという原理に基づいて
細孔径分布を測定するものである。この方法の詳細は、
成書、ファイン・メジャーメント(Fine Part
icleMeasurement )クライト・オア・
ジュニアおよびジエ・エム・グア2アバアル(C1yd
e・0ff−Jr・and J8M、Dallaval
le )共著、ザeマクミラ7−カ/パニイ、ニュー・
ヨーク(テhe MacmillanCompany 
、 New York ) 1959年に記載されてい
る。この方法では35〜noXtでの細孔径分布を測定
することが可能である。
In this method, mercury is injected into a porous material, and the amount of mercury pores (the amount of mercury infiltrated per unit weight) is determined from the amount of mercury infiltrated. The pore size distribution is measured based on the principle that the pressure required to perform the process is inversely proportional to the pressure required to perform the process. For more information on this method, see
Book, Fine Measurement (Fine Part)
icleMeasurement)
Junior and G.M. Gua2Abaal (C1yd
e・0ff-Jr・and J8M, Dallaval
le) Co-author, Thee Macmilla 7-ka/Panii, New
York (Te he Macmillan Company
, New York) in 1959. With this method, it is possible to measure the pore size distribution at 35 to noXt.

本発明における平均細孔径とは、横軸に細孔径(r)を
対数目盛で表わし、縦軸をdV/d1wr (こヒで、
Vはポロシメーターで測定した累積水銀孔量)で表わす
孔径分布図において、上記文献の方法によって得られた
細孔径分布ta−と横軸とで囲まれる閉区間を左右等面
積に縦軸に平行に区切ったときの横軸上の細孔径値と定
義する。
The average pore diameter in the present invention means the pore diameter (r) expressed on a logarithmic scale on the horizontal axis, and dV/d1wr (dV/d1wr) on the vertical axis.
In the pore size distribution map represented by V (cumulative mercury pore volume measured with a porosimeter), the closed section surrounded by the pore size distribution ta obtained by the method in the above literature and the horizontal axis is parallel to the vertical axis with equal areas on the left and right. Defined as the pore diameter value on the horizontal axis when divided.

本発明において、孔とはその孔径が40X以上も染、か
つ表面からの連通孔と定義し、水銀孔量もその孔に由来
する値である。
In the present invention, pores are defined as pores with a diameter of 40X or more and communicating from the surface, and the amount of mercury pores is also a value derived from the pores.

疎水性の固体の水鎖孔量は、前述の平均細孔径と同じく
水銀圧入式ポロシメーターによシ測定される値であるが
、0,1 wl/f以上4−72未満であることが好ま
しく、0.!!d/f以上3−/を未満であることがよ
)好ましい。
The water chain pore volume of the hydrophobic solid is a value measured by a mercury intrusion porosimeter like the above-mentioned average pore diameter, but it is preferably 0.1 wl/f or more and less than 4-72, 0. ! ! (d/f or more and less than 3-/) is preferable.

本発明における疎水性の固体は粒状であることが必要で
あシ、球形であることが分離効率を向上させる上で好ま
しい。七〇粒径範囲は、水中において40ミクロン以上
800ミクロン未満、好まL<は4oミクロン以上20
0ミクロン未満、さらに好ましくは40ミクロン以上7
5ミクロン未本発明におけるT細胞分離材は、前記した
多孔性表面を有する疎水性の固体に蛋白質を付着せしめ
たもの中ある。
The hydrophobic solid in the present invention needs to be granular, and is preferably spherical in order to improve separation efficiency. 70 Particle size range is 40 microns or more and less than 800 microns in water, preferably L< is 4o microns or more and 20 microns or more.
Less than 0 microns, more preferably 40 microns or more7
The T cell separation material of the present invention, which is less than 5 microns, is one in which a protein is attached to the hydrophobic solid having a porous surface as described above.

付着の除用いる動物血清蛋白質溶液は、1.7f/dj
以上の蛋白質を含む液、好ましくは1.7F/dj以上
の自己血清、哺乳動物の胎児血清を含む培養液もしくは
緩衝液、さらに好ましくは2.5f/d1以上のの哺乳
動物の胎児血清を含む培養液もしくは緩衝液である。本
発明に用いうる哺乳動物の例としては、牛、馬、羊、山
羊、クサイ、マウス、ラット、モルモットなどを挙ける
ことができる。
The animal serum protein solution used for adhesion removal is 1.7f/dj
A solution containing the above proteins, preferably an autologous serum of 1.7 F/dj or more, a culture solution or buffer containing fetal mammalian serum, more preferably a fetal serum of a mammal of 2.5 f/d1 or more. It is a culture solution or a buffer solution. Examples of mammals that can be used in the present invention include cows, horses, sheep, goats, horsetails, mice, rats, and guinea pigs.

付着方法は、多孔性表面、を有する疎水性の固体を、上
記蛋白質を含む液中に浮遊させ、1時間以上、好ましく
Fil 0時間以上静置し、その後、吸引濾過によシ蛋
白質を含む液を除き1.凍結真空乾燥を行なう。
The adhesion method involves suspending a hydrophobic solid having a porous surface in the above-mentioned protein-containing solution, allowing it to stand for at least 1 hour, preferably at least 0 hours, and then filtering the protein-containing solution by suction filtration. Except for 1. Perform freeze-vacuum drying.

静置温度は、蛋白質が変質しない温度であればいずれで
もよく、4℃から室温(18〜25℃)の範囲が好まし
い。
The standing temperature may be any temperature at which the protein does not deteriorate, and is preferably in the range of 4°C to room temperature (18 to 25°C).

本発明で云う白血球浮遊液とは、リンパ球、顆粒球、単
球などの白血球が浮遊してお如、赤血球の混入は白血球
数の10倍以内の1のを云い、遠心法、比重遠心法、デ
キスト2ノ沈澱法等いずれの方法によシ調製し良もので
もよいが、比重遠心法の方が顆粒球および赤血球の混入
が少なく実用的である。
The leukocyte suspension referred to in the present invention refers to a suspension containing white blood cells such as lymphocytes, granulocytes, and monocytes, with red blood cell contamination within 10 times the number of white blood cells. It may be prepared by any method such as , dextrin precipitation, etc., but the specific gravity centrifugation method is more practical since it is less likely to be contaminated with granulocytes and red blood cells.

本発明の!細胞分離材において、疎水性の同体に蛋白質
を付着せしめたことによシ、T細胞の非特異的付着を防
止する良めに、分離に先立ちその度に分離材に蛋白質処
璃をする必要がなくなシ、分離操作が簡便になシ便利で
ある。
The invention! In cell separation materials, since proteins are attached to hydrophobic substances, it is necessary to treat the separation material with protein each time prior to separation in order to prevent non-specific attachment of T cells. It is convenient because it does not need to be removed and the separation operation is simple.

また、T細胞分離材と白血球の接触に際して、0.1f
/dj以上の蛋白質を含む液、好ましくは0.1f/d
1以上の自己血清、動物血清、哺乳動物の胎児血清を含
む培養液もしくは緩衝液、さらに好ましくは◎、597
41以上の哺乳動物の胎児血清を含む培養液もしくは緩
衝液を用いればよく、分離の際に使用する蛋白質量はど
く少量ですむ。前記蛋白質鵞含む液の上@Fistld
i位まで可能であるが、本発明の効果を発揮する範囲と
しては297d1位まで上記効果は、T細胞分離材と白
血球の接触の際、予め付着せしめられた蛋白質が徐々に
溶解する良め、分離材の周8&c高淡度な蛋白質域がで
き、少量の蛋白質を含む液中においても、非T細胞の付
着に何も悪影響を及埋さず、T細胞が非ex的に封着す
ると七が防止できるため発現される。
In addition, when the T cell separation material and leukocytes come into contact, 0.1f
/dj or more, preferably 0.1f/d
A culture solution or buffer containing one or more autologous serum, animal serum, or fetal fetal serum, more preferably ◎, 597
A culture solution or buffer solution containing fetal serum of a mammal with a serum concentration of 41 or higher may be used, and the amount of protein used during separation can be very small. Above the solution containing the protein @Fistld
Although it is possible up to position i, the effect of the present invention can be achieved up to position 297d1. A high-density protein region is formed around the separation material, and even in a solution containing a small amount of protein, there is no adverse effect on the adhesion of non-T cells, and when T cells are attached non-externally, seven It is expressed because it can be prevented.

本発明のT細胞分離材社、乾燥状態であるため、カラム
に充填した状態で容易に7滅菌することが可能であ〉、
よシ無菌操作が容易になる。
Since the T cell separation material of the present invention is in a dry state, it can be easily sterilized when packed in a column.
Aseptic operation becomes easier.

また、滅菌徒長期間の保存が可能になシ、多数のカラム
を常時滅菌状態で準備できる。さらに、滅菌状態で分離
材の充填されたカラムの持ち運びが容易くできる。
In addition, sterile storage can be stored for a long period of time, and a large number of columns can be prepared in a sterile state at all times. Furthermore, the column filled with separation material can be easily carried in a sterile state.

不発91において、疎水性を有する多孔性囲体へ付着せ
しめる蛋白質、およびi細胞分離材と白血球を接触させ
る液中の蛋白質として、哺乳動物の胎児血清蛋白質を用
いている。該胎児血清蛋白質は、T細胞の非特異的付着
を防止するとと4に、B細胞、単球などの非T細胞を特
異的に付着する効果を持つ。
In Misaki 91, mammalian fetal serum protein is used as the protein attached to the hydrophobic porous envelope and the protein in the liquid that brings the i-cell separation material into contact with leukocytes. The fetal serum protein has the effect of preventing non-specific adhesion of T cells and (4) specifically adhering non-T cells such as B cells and monocytes.

この効果は、該胎児血清蛋白質中のなんらかの成分が分
離材に付着したため発現されると考えらこの効果発現に
寄与する胎児血清成分は十分解明されておらず、単一の
蛋白質か、−以上の4のかは現在のところ不明である。
This effect is thought to be caused by some component of the fetal serum protein adhering to the separation material.The fetal serum component contributing to this effect has not been fully elucidated, and may be due to a single protein or - or more. 4 is currently unknown.

しかし、胎児血清の個体差はあまり認められていないと
ころから、胎児血清の基本的成分であることは間違いな
いと以上のことから、本発明は、白血球浮遊液よシきわ
めて簡便、迅速に高収率、高純度でT細胞を分離する効
果をもつものである。
However, since there are not many individual differences in fetal serum, there is no doubt that it is a basic component of fetal serum. Based on the above, the present invention can be used in a very simple, rapid and high-yield manner using a leukocyte suspension. It is effective in isolating T cells with high efficiency and purity.

本発明に用いるT細胞分離器の1例を図面に基づいて説
明すると、白血球浮遊液ならびに洗浄液を注入する入口
1と、白血球浮遊液ならびに洗浄液を流出させる出口2
とを持ったカラム3に、出口の所KT#fil胞分離材
が流出しない程度の孔径を有するフィルタ−4を取シ付
け、カラム3内に前記したT細胞分離材5が充填されて
なるものである。
An example of the T cell separator used in the present invention will be described based on the drawings. An inlet 1 injects a leukocyte suspension and a washing solution, and an outlet 2 through which the leukocyte suspension and washing solution flow out.
A filter 4 having a pore size large enough to prevent the KT#fil cell separation material from flowing out is attached to the column 3 having an outlet, and the column 3 is filled with the above-mentioned T cell separation material 5. It is.

なお、フィルター4は入口側にも設けてよい。Note that the filter 4 may also be provided on the inlet side.

上記の如きT細胞分離器を用いて白血球からT細胞を分
離するには、まず血液から遠心法、比重遠心法女どの方
法に、↓シ調整した白血球を0.If/dj以上の蛋白
質を含む液に浮遊せしめる。この液をあらかじめ0.1
f/dJ以上の蛋白質を含む液で分離材を湿潤状態にし
た分離器に注入し、浮遊液が本発明のテ細砲分離材に浸
潤し終った時点で流出を止め、一定時間静置し、その後
、洗浄液を流して未付着細胞を洗い出すことkより行う
To separate T cells from white blood cells using a T cell separator such as the one described above, firstly, prepare white blood cells from blood by centrifugation or specific gravity centrifugation. Float in a solution containing protein with If/dj or higher. Add this liquid to 0.1
The separation material is injected into a separator moistened with a liquid containing protein of f/dJ or more, and when the floating liquid has completely infiltrated into the gun separation material of the present invention, the outflow is stopped and allowed to stand for a certain period of time. , Then, wash out non-adherent cells by flowing a washing solution.

以上の方法によシ洗い出した洗浄液中に#i、!細胞が
含まれることとなる。
#i in the cleaning solution washed out by the above method! cells will be included.

白血球浮遊液の分離器中での静置時間は、非T細胞のT
IIA胞分離材への付着を十分に行うために、30分か
ら60分程靜装する仁とが好ましい。
The standing time of the leukocyte suspension in the separator is
In order to ensure sufficient adhesion to the IIA cell separation material, it is preferable to leave the mixture undisturbed for about 30 to 60 minutes.

分離操作の際の温度は、細胞障害を与えない温度であれ
ばいずれでもよいが、室温(18〜25℃)からs7℃
@度の範囲が好ましい。
The temperature during the separation operation may be any temperature as long as it does not cause cell damage, but it may range from room temperature (18 to 25°C) to 7°C.
A range of @ degrees is preferable.

このようにして得られ7’LT細胞は、生存率、幼若化
能〜抗体産生調節能など#iいずれも、分離操作前と比
較して変化は認められなかった。
Regarding the 7'LT cells thus obtained, no changes were observed in any of #i, including survival rate, blastogenesis ability, and ability to regulate antibody production, compared to those before the isolation procedure.

以下・、実施例を挙げて本発明をより具体的に説明する
Hereinafter, the present invention will be explained in more detail with reference to Examples.

′ 実施例1 分離材の調製: ■ 多孔性を有する一体の調製     □還流冷却器
、ステンレススチール製二枚羽攪拌器、温度計を備えた
3tの三ロフラスコにジビニルベンゼン(純度51−1
不純物として44%のビニルエチルベンゼンを含む、以
下56参ジビニルベンゼンと記す)100f、フタル酸
ジメチル150t、アゾビスイソブチa 二)リル1f
を加え均一溶液にする。さらに部分ケン化ポリビニルア
ルコール1.5F、塩化ナトリウム609を溶解し九蒸
留水150tlfを加え、250 rpmの回転数で攪
拌を行いながら60℃で1時間、70℃で2時間、80
℃で2時間、さらに90℃で4時間加熱した。
' Example 1 Preparation of separation material: ■ Preparation of a porous unit □ Divinylbenzene (purity 51-1
Contains 44% vinyl ethylbenzene as an impurity, hereinafter referred to as 56-divinylbenzene) 100f, dimethyl phthalate 150t, azobisisobutyric a 2) Ryl 1f
Add to make a homogeneous solution. Furthermore, partially saponified polyvinyl alcohol 1.5F and sodium chloride 609 were dissolved, 150 tlf of nine-distilled water was added, and the mixture was heated at 60°C for 1 hour and at 70°C for 2 hours while stirring at 250 rpm.
The mixture was heated at 90°C for 2 hours and then at 90°C for 4 hours.

生成した共重合体は良好な球状であシ、直径sOミク四
ン以上zooozクロン未満の範囲にあシ、平均細孔径
は1400JL、水銀孔量は1.lsd/fであつ良。
The produced copolymer had a good spherical shape, had a diameter in the range of sO micrometers or more and less than zoooz micrometers, had an average pore diameter of 1,400 JL, and a mercury pore volume of 1. It's hot with lsd/f.

■ 蛋白質の付着 該多孔性を有する固体をステンレス飾で分級し、40ミ
クロン以上75ミクロン未満のものを分けとり、リン酸
i衝液加生理食塩水(以下PIlBと略す)に充分浸し
、PH1で洗浄後、吸引枦遇する。
■ Adhesion of proteins Classify the porous solid with a stainless steel plate, separate those with a size of 40 microns or more and less than 75 microns, soak them thoroughly in phosphate i buffered saline (hereinafter abbreviated as PILB), and wash with PH1. After that, you will be attracted to it.

次いで、この多孔性を有する固体を10ロー牛脂児血清
(蛋白含有量!S、4 f/dl ) K充分浸し、室
温(25℃)下で12時間靜装する。その後、吸引V過
によシ牛脂児血清を除き凍結乾燥を行なう。
Next, this porous solid is thoroughly immersed in 10K of low beef tallow serum (protein content: S, 4 f/dl) and left undisturbed at room temperature (25°C) for 12 hours. Thereafter, the tallow serum is removed by suction V and freeze-drying is performed.

このものをT細胞分離材として用いる。This material is used as a T cell separation material.

分離器の作成: 皺分離材2−を、底面に50ミクpンのナイロンネット
のフィルターを取付けた液入口と出口を有する内径10
■諺のアクリル製カラム(図面参照)に充填する。その
後、力2ム入口よシラ0嘔の牛胎児血清を含むPBS 
(蛋白含有量0.45 f/dj )を注入し、この分
離材を湿潤させる。
Creation of separator: Wrinkle separation material 2- is attached to the bottom with a nylon net filter of 50 microns and has an inner diameter of 10 mm with a liquid inlet and outlet.
■Fill into the proverbial acrylic column (see drawing). Then, add PBS containing 200ml of fetal bovine serum to the inlet.
(protein content 0.45 f/dj) to wet the separation material.

以上の操作によシ分離器を作成し良。A separator can be created using the above operations.

分離操作: ヘパリン加ヒト末梢血からイブイウムメトリゾエイト−
フィコール混液(20℃での比重1,077 )を使っ
て、比重遠心法により分離し、PBSで洗浄し九白血球
分画(T細胞64.9−を含み生存率98嘩)を、4X
10・/−の濃度で10参の牛胎児血清を含むPBSに
浮遊させ九液O,S−を調製する。
Separation procedure: Ibium metrizoate from heparinized human peripheral blood
Separation was performed by specific gravity centrifugation using a Ficoll mixture (specific gravity 1,077 at 20°C), washed with PBS, and a nine leukocyte fraction (containing 64.9 T cells, viability 98%) was obtained 4X.
Nine solutions O and S- are prepared by suspending them in PBS containing 10 ml of fetal bovine serum at a concentration of 10./-.

このものを分離器入口よシ靜かに流し込み、浮遊分離材
に浸透し終った時点で、液の出 口を閉じて流出を止めた。その後、57℃1時間靜置後
、出口を開いて、PBS4−をカラ五入口から流し込み
、自然落下の流速で分離材に吸着し“τ二″:::::
丁°“°“°′。
This liquid was quietly poured into the separator inlet, and when it had permeated the floating separation material, the liquid outlet was closed to stop the liquid from flowing out. Then, after standing at 57°C for 1 hour, the outlet was opened, and PBS4- was poured from the empty inlet, and it was adsorbed to the separation material at the flow rate of gravity and "τ2":::::
ding°“°“°′.

全細胞回収率は、自動血球計数器ま+a血球計算器を使
っての顕微鏡観察によシ求めた。また、i細胞をノイラ
ミニダーゼ処理羊赤血球とのロゼツト反応により求めた
The total cell recovery rate was determined by microscopic observation using an automatic hemocytometer or a hemocytometer. In addition, i-cells were determined by rosette reaction with neuraminidase-treated sheep red blood cells.

°ンブルーによる色素排除 試験法により求めた。Exclusion of dye by °ne blue Determined by test method.

結果は表1に示す。The results are shown in Table 1.

実施例2 で使用した40ミクロン以上75ミク ロン未満の粒径の多孔性を有する固体に、75−の牛胎
児血清を含むPBII (蛋白含有量2.5f/dj)
を用い、実施例1と同様に付着、乾燥したものを同様の
カラムに充填、湿潤させたもの麿↑細胞分離器とする。
PBII (protein content 2.5 f/dj) containing 75-fetal bovine serum was added to the porous solid with a particle size of 40 microns or more and less than 75 microns used in Example 2.
The cells were adhered and dried in the same manner as in Example 1, and then filled into the same column and moistened to form a cell separator.

実施例1と同一白血球浮遊液を用い、同一の分離操作を
施した後の結果を表IK示す。
The same leukocyte suspension as in Example 1 was used and the same separation procedure was performed, and the results are shown in Table IK.

実施例3 実施例1で使用した反応容器に、56−ジピニルベンゼ
ン100f、)ルエンS OOf、アゾビスイソブチロ
ニトリル1fを加え均一溶液とする。
Example 3 Into the reaction vessel used in Example 1, 100 f of 56-dipynylbenzene, ) luene SOOf, and 1 f of azobisisobutyronitrile were added to form a homogeneous solution.

以下実施例1と同様の操作を施し、球状の共重合体を得
た。このものの粒径範囲は、30ミクpン以上1ooo
ミクロン未満であり、平均細孔径はzsoojL、水銀
孔量社2.9d/fであった。
Thereafter, the same operations as in Example 1 were performed to obtain a spherical copolymer. The particle size range of this product is 30 microns or more and 100 microns or more.
The average pore diameter was zsoojL, 2.9 d/f (Mercury Pore Co., Ltd.).

この4の140ミクロン以上75ミクロン未満の範囲で
湿式分級し、実施例1と同様に蛋白質を付着、乾燥させ
たものを同様のカラムに充填、湿潤させたものをT細胞
分離器とする。
This 4 was subjected to wet classification in the range of 140 microns to less than 75 microns, and proteins were attached and dried in the same manner as in Example 1, and the same column was filled and moistened to form a T cell separator.

実施例1と同一白血球浮遊液を用い、同一の分離操作を
施し友後の結果を表1に示す。
The same leukocyte suspension as in Example 1 was used and the same separation procedure was performed, and the results are shown in Table 1.

実施例4 実施例1で使用した反応容器に、56−ジビニルベンゼ
ン100 f、アジピン酸ジオクチル150tアゾビス
イソブチロニトリル1fを加え均一溶液とする。以下、
実施例1と同様の操作を施し、球状の共重合体を得九。
Example 4 Into the reaction vessel used in Example 1, 100 f of 56-divinylbenzene, 150 t of dioctyl adipate, and 1 f of azobisisobutyronitrile were added to form a homogeneous solution. below,
The same operation as in Example 1 was performed to obtain a spherical copolymer.

このものの粒径範囲は30ミクロン以上500ミクロン
未満であシ、平均細孔径11oo1.水銀孔量は1.7
d/fであった。
The particle size range of this material is 30 microns or more and less than 500 microns, and the average pore size is 110. Mercury porosity is 1.7
It was d/f.

このものを40ミクロン以上75ミクロン未満の範囲で
湿式分級し、実施例1と同様に蛋白質を付着、乾燥させ
たものを同様のカラムに充填、湿潤させたものをT細胞
分離器とする。
This product is wet-classified in the range of 40 microns or more and less than 75 microns, coated with proteins in the same manner as in Example 1, dried, and filled into the same column, and moistened to form a T cell separator.

実施例1と同一白血球浮遊液を用い、同一の分離操作を
施した後の結果を表1に示す。
The same leukocyte suspension as in Example 1 was used and the same separation procedure was performed, and the results are shown in Table 1.

実施例5 実施例1で調製し良多孔性を有する固体を75ミクロン
以上200ミクロン未満の範囲で湿式分級し、実施例1
と同様に蛋白質を付着、乾燥させ、同様のカラムに充填
、湿潤させ九屯のをT@胞分離器とする。      
        。
Example 5 The solid having good porosity prepared in Example 1 was wet classified in the range of 75 microns or more and less than 200 microns.
Proteins are attached and dried in the same manner as above, packed into a similar column, and moistened to form a T@ cell separator in Jiutun.
.

実施例1と同一白血球浮遊液を用い、同=・の分離操作
を施した後の結果を表1に示す。
Table 1 shows the results after performing the same separation procedure using the same leukocyte suspension as in Example 1.

比較例1 実施例1に用い九と同一の多孔性を有する固体式分級し
良ものをPH1に充分浸し、i浄後、蛋白質の付着、乾
燥を行なうことな〈実施例1と同様の力2ムに充填し、
分離器として用いた。
Comparative Example 1 A solid-class classified material having the same porosity as that used in Example 1 was thoroughly immersed in PH1, and after i-cleaning, the protein was not attached or dried. fill the tank,
It was used as a separator.

前もって分離材を10−の牛胎児血清を含むPI34−
で平衡化した後、実施例1と同一白血球浮遊液を用い、
同一の分離操作を施した後の結果を表1に示す。
Preliminary isolation material was prepared using PI34 containing 10-ml fetal bovine serum.
After equilibration with , using the same leukocyte suspension as in Example 1,
Table 1 shows the results after performing the same separation operation.

ナイロンファイバー(和光純薬工業株式会社から購入J
をピンセットでよくほぐし、00Stを5−容量の7ラ
スチツク注射器に入れ、2.5mgの目盛まで均一につ
めた。該注射器に5−の牛胎児血清を含むPI3を満た
し、1時間放置後、実施例1で用い良ものと同一のリン
パ球浮遊液を0.5−上部よシ注入し、37℃で1時間
放置した後、PI310−にて2−7分の流速で非吸着
細胞を流出させ、!細胞分画を得喪。
Nylon fiber (purchased from Wako Pure Chemical Industries, Ltd.)
was loosened well with tweezers, and 00St was put into a 5-capacity 7-last syringe and filled uniformly to the 2.5 mg mark. The syringe was filled with PI3 containing 5-ml fetal bovine serum, left for 1 hour, and then the same lymphocyte suspension used in Example 1 was injected into the upper part of the syringe and heated at 37°C for 1 hour. After standing, non-adsorbed cells were flowed out using PI310- at a flow rate of 2-7 minutes. Obtain cell fractionation.

結果を表1に示す。The results are shown in Table 1.

Ta−生存率−回収率一 実施例1     ? 3,1    98    8
 ?、612    918     97     
85.4#  3    92,4     96  
   76.9#  4    90,7     9
8     85.1#  5    91,0   
  98     91.?比較@ 1    92,
0    97    4 s、b#  2    8
7,8     96     31,0′  以上説
明したように本発明によれば、白血球浮遊液から’rg
胞を免疫的に刺激せず、高純度、高収率−で分離でき、
さらに分離に際して、ごく少量の蛋白質の使用で迅速、
簡便かつ、よシ無菌的に分離を行なえる効果がある。
Ta-survival rate-recovery rate - Example 1? 3,1 98 8
? , 612 918 97
85.4# 3 92,4 96
76.9# 4 90,7 9
8 85.1# 5 91,0
98 91. ? Comparison @ 1 92,
0 97 4 s, b# 2 8
7,8 96 31,0' As explained above, according to the present invention, 'rg
It does not irritate cells immunologically and can be isolated with high purity and high yield.
Furthermore, during separation, the use of a very small amount of protein allows rapid,
It has the effect of allowing simple and sterile separation.

【図面の簡単な説明】[Brief explanation of drawings]

図面は本発明のTi1l胞分離器の一例を示す断面図で
ある。 1・・・・・・・・・液の入口    2・・・・・・
・・・液の出口3・・・・・・・・・ 力2ム    
 4・・・・・・・・・ フィルター5・・・・・・・
・・ T細胞分離材
The drawing is a sectional view showing an example of the Ti1l cell separator of the present invention. 1・・・・・・・・・Liquid inlet 2・・・・・・
...Liquid outlet 3... Force 2m
4...... Filter 5...
・・T cell isolation material

Claims (1)

【特許請求の範囲】 1、動物血−蛋白質を付着せしめた500ス以上5oo
oJL未満の平均細孔径を有する疎水性かつ水不溶性の
多孔性固体よシなる白血球浮遊液から!細胞を分離する
!細胞分離材。 乳液の出入口を有し、かつ少なくとも該液出口側にフィ
ルタ。−を設は九カラム内に、動物血清蛋白質を付着せ
しめ7tsooX以上5oooX未満の平均細孔径を有
する疎水性かつ水、歪溶性の多孔性向体よシなる白血球
浮遊液から!細胞を分離するT細胞分離材を充填してな
る!細胞分離器。 5、動物血清蛋白質!付着せしめた500!以上56o
oX未轡の平均細孔径を有する疎水性かつ水不溶性の多
孔性固体よシなる白血球浮遊液からT細胞、を分離する
分離材に、0.1f/dj以上の蛋白質を含む液中で白
血球浮遊液鵞接触させることを特徴とする白血球浮遊液
から!細胞を分離する方、4.動物血清蛋白質が哺乳動
物の胎児、血清蛋白質である特許請求の範−第3項記載
の白血球浮遊液からT細胞を分離する方法。
[Scope of Claims] 1. Animal blood - 500 or more 5oos to which proteins are attached
From a leukocyte suspension as a hydrophobic and water-insoluble porous solid with an average pore size of less than oJL! Separate cells! Cell separation material. It has an inlet and outlet for the emulsion, and a filter at least on the outlet side of the emulsion. - A leukocyte suspension containing hydrophobic, water-distortion soluble, porous cells having an average pore diameter of 7 to 500X to which animal serum proteins are attached is prepared in a nine-column column. Filled with T cell separation material that separates cells! Cell separator. 5. Animal serum protein! 500 attached! More than 56o
The separation material for separating T cells from a leukocyte suspension, which is a hydrophobic and water-insoluble porous solid having an average pore diameter of 0.0X, is a separation material for leukocytes suspended in a solution containing protein of 0.1 f/dj or more. From leukocyte suspension, which is characterized by contact with liquid! Those who separate cells, 4. 4. The method for separating T cells from a leukocyte suspension according to claim 3, wherein the animal serum protein is a mammalian fetal serum protein.
JP56172153A 1981-10-29 1981-10-29 Material, unit and process for separating t-cells Granted JPS5874611A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP56172153A JPS5874611A (en) 1981-10-29 1981-10-29 Material, unit and process for separating t-cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56172153A JPS5874611A (en) 1981-10-29 1981-10-29 Material, unit and process for separating t-cells

Publications (2)

Publication Number Publication Date
JPS5874611A true JPS5874611A (en) 1983-05-06
JPS6245206B2 JPS6245206B2 (en) 1987-09-25

Family

ID=15936542

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56172153A Granted JPS5874611A (en) 1981-10-29 1981-10-29 Material, unit and process for separating t-cells

Country Status (1)

Country Link
JP (1) JPS5874611A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010151521A (en) * 2008-12-24 2010-07-08 Canon Inc Target substance detection element and method of manufacturing the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010151521A (en) * 2008-12-24 2010-07-08 Canon Inc Target substance detection element and method of manufacturing the same

Also Published As

Publication number Publication date
JPS6245206B2 (en) 1987-09-25

Similar Documents

Publication Publication Date Title
Rogers et al. Characterization of a protein-lipopolysaccharide complex released from cell walls of Pseudomonas aeruginosa by ethylenediaminetetraacetic acid
CA1174600A (en) Encapsulation of live animal cells
CN108136112A (en) For the Multifunction blood biocompatible porous polymeric beads sorbent of toxin and potassium of the removal based on protein from biofluid
JPS5936963B2 (en) T cell isolation material and isolation method
JPH0374207B2 (en)
CN103826451B (en) For removing the polymer sorbent of impurity from whole blood and blood products
Van De Vyver Phenomena of cellular recognition in sponges
Bouck Stratification and subsequent behavior of plant cell organelles
CN106635769B (en) Cell separation apparatus and cell isolation method
JPS5874611A (en) Material, unit and process for separating t-cells
Heller et al. Purification of bovine retinal pigment epithelial cells by dissociation in calcium free buffers and centrifugation in Ficoll density gradients followed by “recovery” in tissue culture
CN106039448B (en) AIDS cell adsorbing therapy instrument
Perlmann Study on the effect of antisera on unfertilized sea urchin eggs
CA1059902A (en) Diagnostic process
JPH0558707B2 (en)
Lopez et al. Thymocytes, macrophages, and erythrocytes
US20060254963A1 (en) Cell separation and collection apparatus and separation and collection method
Thompson et al. A method for size separation of murine spleen cells using counterflow centrifugation
Duffus et al. The kinetics and morphology of rosette-forming cell response in the popliteal lymph nodes of rats
CN106267415B (en) AIDS purification treatment instrument
CN106267409B (en) AIDS biological therapy reactor
CN106267424B (en) AIDS immune cell therapy instrument
JPS5917387B2 (en) Method and device for separating lymphocytes into T cells and B cells
Churney et al. The effect of excess potassium on the cortex of the fertilized egg of arbacia punctulata
JPH02167071A (en) Separating material for leukocytic cell of nonhuman animal origin, separator therefor and separation thereof